StonvexLoading…
StonvexStonvexStonvexCore line items from BTSG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-30 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $3.74B | $3.61B | $12.91B | $9.36B | $6.03B |
Operating Income | Not available | $121.45M | $295.25M | $187.14M | $99.30M |
Net Income | Not available | $148.77M | $190.67M | $113.59M | $57.75M |
EPS (Diluted) | $0.40 | $0.67 | $0.87 | $0.52 | $0.27 |
Total Assets | Not available | $6.21B | $6.41B | $6.05B | $5.94B |
Total Liabilities | Not available | $4.22B | $4.53B | $4.23B | $4.20B |
Cash & Equivalents | Not available | $888.80M | $88.37M | $140.34M | $70.07M |
Free Cash Flow OCF − CapEx | Not available | $101.40M | $394.69M | $200.79M | $108.62M |
Shares Outstanding | Not available | 193.21M | 192.12M | 180.69M | 177.06M |